BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 24088646)

  • 1. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
    Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
    Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner.
    Ok WJ; Cho HJ; Kim HH; Lee DH; Kang HY; Kwon HW; Rhee MH; Kim M; Park HJ
    J Atheroscler Thromb; 2012; 19(4):337-48. PubMed ID: 22498765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
    Chen TG; Lee JJ; Lin KH; Shen CH; Chou DS; Sheu JR
    Chin J Physiol; 2007 Jun; 50(3):121-6. PubMed ID: 17867432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Thrombotic Effects of Artesunate through Regulation of cAMP and PI3K/MAPK Pathway on Human Platelets.
    Yoon SS; Kwon HW; Shin JH; Rhee MH; Park CE; Lee DH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
    Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
    Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of total saponin from Korean Red Ginseng on [Ca(2+)]i mobilization through phosphorylation of cyclic adenosine monophosphate-dependent protein kinase catalytic subunit and inositol 1,4,5-trisphosphate receptor type I in human platelets.
    Shin JH; Kwon HW; Cho HJ; Rhee MH; Park HJ
    J Ginseng Res; 2015 Oct; 39(4):354-64. PubMed ID: 26869828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordycepin-Enriched WIB801C from Cordyceps militaris Inhibits Collagen-Induced [Ca(2+)]i Mobilization via cAMP-Dependent Phosphorylation of Inositol 1, 4, 5-Trisphosphate Receptor in Human Platelets.
    Lee DH; Kim HH; Cho HJ; Yu YB; Kang HC; Kim JL; Lee JJ; Park HJ
    Biomol Ther (Seoul); 2014 May; 22(3):223-31. PubMed ID: 25009703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9.
    Cho HJ; Nam KS
    J Biochem Mol Biol; 2007 Sep; 40(5):678-83. PubMed ID: 17927900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
    Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
    Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.
    Hong Q; Ma ZC; Huang H; Wang YG; Tan HL; Xiao CR; Liang QD; Zhang HT; Gao Y
    Eur J Pharmacol; 2016 Apr; 777():1-8. PubMed ID: 26948317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.
    Cho HJ; Cho JY; Rhee MH; Park HJ
    Eur J Pharmacol; 2007 Mar; 558(1-3):43-51. PubMed ID: 17229422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways.
    Shen DS; Yang YJ; Kong XJ; Ma N; Liu XW; Li SH; Jiao ZH; Qin Z; Huang MZ; Li JY
    Eur J Pharmacol; 2019 Jun; 852():1-13. PubMed ID: 30797789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
    Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
    Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.